Cancer
ROCHESTER, Minn. — A genomic test co-developed by Mayo Clinic and SkylineDx can identify whether people with melanoma are at low or high risk for[...]
Latest stories
Featured News
February 2, 2017
Cancer
February 1, 2017
Medical Innovation
January 31, 2017
Arizona
January 30, 2017
Sign up to receive email notifications
Explore more topics
Sign up
Mayo Clinic Connect
An online patient support community